- Tytuł:
- MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
- Autorzy:
- Temat:
-
alzheimer’s disease
biomarkers
brain amyloid
brain imaging
clinical trial
cognition
cytokines
dementia
hematologic changes
immunomodulation
inflammation
lenalidomide.
Medicine - Źródło:
- Open Access Journal of Clinical Trials, Vol Volume 12, Pp 1-13 (2020)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.dovepress.com/mclena-1-a-phase-ii-clinical-trial-for-the-assessment-of-safety-tolera-peer-reviewed-article-OAJCT; https://doaj.org/toc/1179-1519
- Dostęp URL:
- https://doaj.org/article/c02c0d8e66234263bb8f9772cf795fc3  Link otwiera się w nowym oknie
Czasopismo naukowe